[go: up one dir, main page]

ES2119241T3 - Procedimiento para la obtencion de insulina con puentes de cistina unidos correctamente. - Google Patents

Procedimiento para la obtencion de insulina con puentes de cistina unidos correctamente.

Info

Publication number
ES2119241T3
ES2119241T3 ES95101748T ES95101748T ES2119241T3 ES 2119241 T3 ES2119241 T3 ES 2119241T3 ES 95101748 T ES95101748 T ES 95101748T ES 95101748 T ES95101748 T ES 95101748T ES 2119241 T3 ES2119241 T3 ES 2119241T3
Authority
ES
Spain
Prior art keywords
insulin
procedure
cystine bridges
correctly
united
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95101748T
Other languages
English (en)
Inventor
Rainer Dr Obermeier
Martin Dr Gerl
Jurgen Ludwig
Walter Sabel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2119241T3 publication Critical patent/ES2119241T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA OBTENCION DE INSULINA CON PUENTES DE CISTINA UNIDOS CORRECTAMENTE A PARTIR DE UNA CADENA DE ACIDO AMINO PROINSULINA CORRESPONDIENTE EN PRESENCIA DE MERCAPTANO, SUSTANCIAS AUXILIARES Y UN VALOR DE PH DESDE 10 HASTA 11, ASI COMO LA TRANSFORMACION DIRECTA DE LA PROINSULINA A INSULINA CON LA AYUDA DE ENZIMAS Y AISLAMIENTO DIRECTO DE LA INSULINA A PARTIR DEL CONJUNTO DE REACCION CON LA AYUDA DE RESINA ABSORBEDORA HIDROFOBA.
ES95101748T 1994-02-18 1995-02-09 Procedimiento para la obtencion de insulina con puentes de cistina unidos correctamente. Expired - Lifetime ES2119241T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4405179A DE4405179A1 (de) 1994-02-18 1994-02-18 Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken

Publications (1)

Publication Number Publication Date
ES2119241T3 true ES2119241T3 (es) 1998-10-01

Family

ID=6510552

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95101748T Expired - Lifetime ES2119241T3 (es) 1994-02-18 1995-02-09 Procedimiento para la obtencion de insulina con puentes de cistina unidos correctamente.

Country Status (14)

Country Link
US (1) US5663291A (es)
EP (1) EP0668292B1 (es)
JP (1) JP3863579B2 (es)
KR (1) KR100371824B1 (es)
AT (1) ATE166069T1 (es)
AU (1) AU699817B2 (es)
CA (1) CA2142780C (es)
DE (2) DE4405179A1 (es)
DK (1) DK0668292T3 (es)
ES (1) ES2119241T3 (es)
FI (1) FI115916B (es)
IL (1) IL112680A0 (es)
NO (1) NO318424B1 (es)
SG (1) SG46683A1 (es)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0821006T3 (da) 1996-07-26 2004-08-16 Aventis Pharma Gmbh Insulinderivater med öget zinkbinding
DE19726167B4 (de) 1997-06-20 2008-01-24 Sanofi-Aventis Deutschland Gmbh Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19825447A1 (de) * 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
DE19838097A1 (de) 1998-08-24 2000-03-02 Hoechst Marion Roussel De Gmbh Verfahren zur chromatographischen Reinigung von Insulinen
FI107115B (fi) * 1998-09-30 2001-06-15 Valio Oy Menetelmä naudan insuliinin poistamiseksi
ATE257514T1 (de) 1998-10-09 2004-01-15 Scil Proteins Gmbh Verfahren zur gewinnung von aktivem beta-ngf
JP3406244B2 (ja) 1999-04-30 2003-05-12 伊藤ハム株式会社 新規な融合蛋白質からの組み換えインスリンの製造方法
US6746853B1 (en) 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
AR025646A1 (es) * 2000-09-13 2002-12-04 Beta Lab Sa Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
AU2002316807A1 (en) * 2001-06-08 2002-12-23 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
DE10227232A1 (de) * 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
US7193035B2 (en) * 2002-10-29 2007-03-20 Sanofi-Aventis Deutschland Gmbh Crystals of insulin analogs and processes for their preparation
DE602004025192D1 (de) * 2003-12-05 2010-03-11 Roche Diagnostics Gmbh Rekombinante Carboxypeptidase B und ihre Aufreinigung
DE102004015965A1 (de) 2004-04-01 2005-10-20 Aventis Pharma Gmbh Verfahren zur Gewinnung von Insulinen durch verbesserte Luftbegasung der Faltung
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
DE102006031955A1 (de) 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
RU2495131C2 (ru) * 2008-02-19 2013-10-10 Байокон Лимитид Способ получения рекомбинантного инсулина гларгина
WO2009133529A2 (en) * 2008-04-30 2009-11-05 Wockhardt Research Centre Processes for refolding of insulin
PL219335B1 (pl) * 2008-07-04 2015-04-30 Inst Biotechnologii I Antybiotyków Pochodna insuliny lub jej farmaceutycznie dopuszczalna sól, jej zastosowanie oraz zawierająca ją kompozycja farmaceutyczna
HUE048608T2 (hu) 2008-10-17 2020-08-28 Sanofi Aventis Deutschland Egy inzulin és egy GLP-1 agonista kombinációja
UA91281C2 (ru) * 2008-11-26 2010-07-12 Общество С Ограниченной Ответственностью «Мако» Способ получения рекомбинантного инсулина человека
LT2498801T (lt) 2009-11-13 2018-05-10 Sanofi-Aventis Deutschland Gmbh Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną
RU2537239C2 (ru) 2009-11-13 2014-12-27 Санофи-Авентис Дойчланд Гмбх Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
HUE031181T2 (en) 2010-08-30 2017-06-28 Sanofi Aventis Deutschland Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
BR112013025151B1 (pt) 2011-04-01 2021-09-28 3M Innovative Properties Company Laminação retrorrefletiva
DK2739646T3 (en) * 2011-05-10 2018-02-26 Stefan Hermann COMPREHENSIVE BUFFER SYSTEM FOR RENATURING HUMAN PROINSULIN OR PROINSULIN DERIVATIVES
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US10421795B2 (en) 2012-12-17 2019-09-24 Merck Sharp & Dohme Corp. Process for purifying insulin and analogues thereof
EP3116531B1 (en) 2014-03-14 2021-10-20 Merck Sharp & Dohme Corp. Purifying insulin using cation exchange and reverse phase chromatography in the presence of an organic modifier and elevated temperature
FI3229828T3 (fi) 2014-12-12 2023-05-29 Sanofi Aventis Deutschland Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療
WO2017040363A1 (en) 2015-09-02 2017-03-09 Merck Sharp & Dohme Corp. A process for obtaining insulin with correctly formed disulfide bonds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ196609A (en) * 1980-03-27 1984-02-03 Lilly Co Eli Preparation of proinsulin-like insulin precursors
NZ199391A (en) * 1981-01-02 1985-12-13 Genentech Inc Chimeric polypeptides comprising a proinsulin sequence,and preparation by recombinant dna technique;production of human insulin
US4616078A (en) * 1985-04-08 1986-10-07 Eli Lilly And Company Process for purifying proinsulin-like materials
DE3537708A1 (de) * 1985-10-23 1987-04-23 Boehringer Mannheim Gmbh Verfahren zur aktivierung von t-pa nach expression in prokaryonten
US4877868A (en) * 1986-03-12 1989-10-31 Neorx Corporation Radionuclide antibody coupling
DE4012818A1 (de) * 1990-04-21 1991-10-24 Hoechst Ag Verfahren zur herstellung von fremdproteinen in streptomyceten
EP0347781B1 (de) * 1988-06-23 1994-02-16 Hoechst Aktiengesellschaft Mini-Proinsulin, seine Herstellung und Verwendung
DE3901718A1 (de) * 1989-01-21 1990-07-26 Hoechst Ag Verfahren zur renaturierung falscher rekombinanten von insulinvorlaeufern
GR1005153B (el) * 1989-08-29 2006-03-13 The General Hospital Corporation Πρωτεινες συντηξεως, παρασκευη τους και χρηση τους.
DE4028120C2 (de) * 1990-09-05 1996-09-19 Hoechst Ag Verfahren zur Reinigung von Insulin und/oder Insulinderivaten
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
EP0599303A3 (en) * 1992-11-27 1998-07-29 Takeda Chemical Industries, Ltd. Peptide conjugate
DK0600372T3 (da) * 1992-12-02 1997-08-11 Hoechst Ag Fremgangsmåde til fremstilling af proinsulin med korrekt forbundne cystinbroer.
US5523293A (en) * 1994-05-25 1996-06-04 Iowa State University Research Foundation, Inc. Soy protein-based thermoplastic composition for preparing molded articles

Also Published As

Publication number Publication date
FI115916B (fi) 2005-08-15
HK1010457A1 (en) 1999-06-17
AU699817B2 (en) 1998-12-17
EP0668292A2 (de) 1995-08-23
EP0668292A3 (de) 1996-02-07
EP0668292B1 (de) 1998-05-13
FI950699A0 (fi) 1995-02-16
FI950699L (fi) 1995-08-19
JPH07265092A (ja) 1995-10-17
NO318424B1 (no) 2005-04-18
ATE166069T1 (de) 1998-05-15
CA2142780A1 (en) 1995-08-19
KR100371824B1 (ko) 2003-04-10
SG46683A1 (en) 1998-02-20
IL112680A0 (en) 1995-05-26
AU1228895A (en) 1995-08-31
KR950032282A (ko) 1995-12-20
DE4405179A1 (de) 1995-08-24
DK0668292T3 (da) 1998-11-23
DE59502138D1 (de) 1998-06-18
US5663291A (en) 1997-09-02
JP3863579B2 (ja) 2006-12-27
CA2142780C (en) 2008-10-14
NO950592D0 (no) 1995-02-17
NO950592L (no) 1995-08-21

Similar Documents

Publication Publication Date Title
ES2119241T3 (es) Procedimiento para la obtencion de insulina con puentes de cistina unidos correctamente.
ES2097426T3 (es) Procedimiento para la obtencion de proinsulina con puentes de cistina correctamente unidos.
ES2124373T3 (es) Procedimiento para la preparacion de derivados del acido n-acil-n,n',n'-etilendiamintriacetico.
GB2301363A (en) Human phosphodiesterase type ivc and its production and use
AU638133B2 (en) Ribosome inactivating proteins, inactive precursor forms thereof, a process for making and a method of using
BR0110492A (pt) Composto, composição farmacêutica que compreende esse composto, processo para a preparação de composição farmacêutica, utilização do composto e processo para a preparação do composto
SE8204627D0 (sv) Process for preparing insulin derivatives
PT86552A (de) Gama-glutamyl-transpeptidase deren herstellung und deren verwendung
TW344662B (en) A process for preparing a freeze dried thiotepa composition
NZ503372A (en) Chemical supplementation of bone by exposing bone to a therapeutic compound and applying a potential difference across the bone or tissue
DK0547031T3 (da) N-beskyttede (S)-isoserinforbindelser
DE58905691D1 (de) Verfahren zur Herstellung von L-alpha-Aminosäuren.
AU5982299A (en) Novel process for the cryo-preservation of plants
ES2058224T3 (es) Procedimiento para la hidrolisis enzimatica de compuestos alfa-aminoadipinil-monoaminicos.
IE830451L (en) Detoxified e. coli neurotoxin.
UA10180C2 (uk) Спосіб одержання біологічно активної речовини, що має регенераторну та модулюючу дію
DE59501436D1 (de) Verfahren zur Herstellung von 2-Cyaniminothiazolidin
PT879603E (pt) Antagonista de canais de calcio possuindo uma accao inibidora contra a secrecao da hormona paratiroideia e a sua utilizacao
ATE249467T1 (de) Herstellung von optisch aktiven halohydrintrialkylsilylethern
GB1515487A (en) Process for the preparation of silage
GB2312677A (en) A method of preparing an undifferentiated cell

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 668292

Country of ref document: ES